Establishment of organoid models based on a nested array chip for fast and reproducible drug testing in colorectal cancer therapy

[1] Chae YK(2017)Path toward precision oncology: review of targeted therapy studies and tools to aid in defining “actionability” of a molecular lesion and patient management support Mol Cancer Ther 16 2645-2655

[2] Pan AP(2020)Shifting, overlapping and expanding use of “precision oncology” terminology: a retrospective literature analysis BMJ Open 10 e036357-1505

[3] Davis AA(2020)Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO precision medicine working group Ann Oncol 31 1491-296

[4] Tran A(2019)Targeted next generation sequencing as a tool for precision medicine BMC Med Genomics 12 81-4699

[5] Klossner Q(2021)Integrated analysis of whole genome and epigenome data using machine learning technology: toward the establishment of precision oncology Front Oncol 11 666937-579

[6] Crain T(2010)Three-dimensional tissue culture based on magnetic cell levitation Nat Nanotechnol 5 291-71

[7] Mosele F(2021)Patient-derived xenograft engraftment and breast cancer outcomes in a prospective neoadjuvant study (beauty) Clin Cancer Res 27 4696-1026

[8] Remon J(2019)Organoids—Preclinical models of human disease New Engl J Med 380 569-187

[9] Mateo J(2017)organoids Nat Methods 15 1-926

[10] Gulilat M(2021)Hedgehog transcriptional effector GLI mediates mTOR-induced PD-L1 expression in gastric cancer organoids Cancer Lett 518 59-941

[1] Chae YK(2017)Path toward precision oncology: review of targeted therapy studies and tools to aid in defining “actionability” of a molecular lesion and patient management support Mol Cancer Ther 16 2645-2655

[2] Pan AP(2020)Shifting, overlapping and expanding use of “precision oncology” terminology: a retrospective literature analysis BMJ Open 10 e036357-1505

[3] Davis AA(2020)Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO precision medicine working group Ann Oncol 31 1491-296

[4] Tran A(2019)Targeted next generation sequencing as a tool for precision medicine BMC Med Genomics 12 81-4699

[5] Klossner Q(2021)Integrated analysis of whole genome and epigenome data using machine learning technology: toward the establishment of precision oncology Front Oncol 11 666937-579

[6] Crain T(2010)Three-dimensional tissue culture based on magnetic cell levitation Nat Nanotechnol 5 291-71

[7] Mosele F(2021)Patient-derived xenograft engraftment and breast cancer outcomes in a prospective neoadjuvant study (beauty) Clin Cancer Res 27 4696-1026

[8] Remon J(2019)Organoids—Preclinical models of human disease New Engl J Med 380 569-187

[9] Mateo J(2017)organoids Nat Methods 15 1-926

[10] Gulilat M(2021)Hedgehog transcriptional effector GLI mediates mTOR-induced PD-L1 expression in gastric cancer organoids Cancer Lett 518 59-941